Elsevier Launches Malaria Nexus, Global Malaria Resource

New online knowledge hub aims to become leading forum for malaria researchers, editors and opinion leaders

Oxford, 11 August, 2010 – Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier’s Global Malaria Resource, www.malarianexus.com.

Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier’s leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet®The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.

“The aim of Malaria Nexus is to be a comprehensive resource and hub of knowledge for malaria researchers worldwide” said Dale Seaton, Executive Publisher for Parasitology, at Elsevier. “As well as making our latest malaria publications free to download, we want to go beyond the article, and become a leading forum for discussion between researchers, editors and opinion leaders.”

The site features interviews with key authors, who can expand on their highlighted published work, as well as editors of some of Elsevier’s most prestigious journal titles. Active participation and feedback from interested parties is encouraged. Currently featuring article feeds from 13 journals, the site will include additional relevant journals over the coming months.

John Beier, Editor of the participating journal Acta Tropica, said, “From remote settings in malaria endemic areas to sophisticated laboratories, malaria researchers from around the world will certainly benefit from using Malaria Nexus by reading timely highlights of first class publications, learning the views of leading malaria experts, and expressing their important opinions in this new forum for exchange of information.”

For more information visit the site www.malarianexus.com and register for updates.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact
Matthew Smaldon
Group Marketing Communications Manager - Elsevier
(+44) 01865 843644
M.smaldon@elsevier.com